CORC  > 湖南大学
STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy.
Wei-Jing Gong; Li-Yun Ma; Lei Hu; Yong-Ning Lv; Hong Huang; Jia-Qiang Xu; Dan-Dan Huang; Rui-Jie Liu; Yong Han; Yu Zhang
刊名International journal of clinical oncology
2019
关键词Lung cancer Platinum-based chemotherapy Prognosis STAT3 rs4769793 Susceptibility
ISSN号1437-7772
URL标识查看原文
公开日期[db:dc_date_available]
内容类型期刊论文
URI标识http://www.corc.org.cn/handle/1471x/4736907
专题湖南大学
作者单位1.Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. Department of Pharmacy, Peking University People's Hospital, 100044, Beijing, China. Wuhan Highway Management Office, Wuhan, 430000, China. Department of Nursing, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. Department of Pathology, Xiangya Hospital, Central South University, Changsha, 410008, China. Department of Pharmacy, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, 430022, China. sanlan2000@16
2.com.
推荐引用方式
GB/T 7714
Wei-Jing Gong,Li-Yun Ma,Lei Hu,et al. STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy.[J]. International journal of clinical oncology,2019.
APA Wei-Jing Gong.,Li-Yun Ma.,Lei Hu.,Yong-Ning Lv.,Hong Huang.,...&San-Lan Wu.(2019).STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy..International journal of clinical oncology.
MLA Wei-Jing Gong,et al."STAT3 rs4796793 contributes to lung cancer risk and clinical outcomes of platinum-based chemotherapy.".International journal of clinical oncology (2019).
个性服务
查看访问统计
相关权益政策
暂无数据
收藏/分享
所有评论 (0)
暂无评论
 

除非特别说明,本系统中所有内容都受版权保护,并保留所有权利。


©版权所有 ©2017 CSpace - Powered by CSpace